Well seems like 1M dosing maybe a little short.  IF FDA approves, hopefully those in charge of study will take C19 dosing and begin the P3b trial with MD2.  Get paid for second study.  This is becoming an investment rather than dead money.  Maybe a big offer in partnership from BP.  

For our scientist, know you will not like this, speculation, if C19 vaccine is not permanent, more like the flu vaccine, mRNA is not fixed.  Annual C19 vaccine and ABL becomes a household prescription.  Think of it,

Maybe one to two billion taking ABL.  Now that would run into money.   sidebar, yes just speculation, but that is why we stay invested.  There is so little we know!